[TNGX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 11.46%
YoY- -2.77%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 5,431 10,732 14,598 5,766 6,411 6,920 5,771 -3.95%
PBT -30,716 -22,240 -20,646 -28,008 -29,009 -29,050 -24,855 15.11%
Tax 47 23 64 -2,278 51 -873 3 522.98%
NP -30,763 -22,263 -20,710 -25,730 -29,060 -28,177 -24,858 15.22%
Tax Rate - - - - - - - -
Total Cost 36,194 32,995 35,308 31,496 35,471 35,097 30,629 11.73%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -566.43 -207.45 -141.87 -446.24 -453.28 -407.18 -430.74 19.96%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 -0.28 9.28%
EPS Diluted -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 -0.28 9.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.